Log in to save to my catalogue

Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma mu...

Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma mu...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_815966021

Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme

About this item

Full title

Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme

Publisher

Boston: Springer US

Journal title

Journal of neuro-oncology, 2011-01, Vol.101 (2), p.179-188

Language

English

Formats

Publication information

Publisher

Boston: Springer US

More information

Scope and Contents

Contents

We have previously shown that expanded/activated γδ T cells from healthy donors are cytotoxic to GBM cell lines and primary GBM explants. In this report, we examined the therapeutic effect of intracranial infusion of expanded/activated γδ T cells on human minimal and established U251 tumor xenografts in athymic nude mice. Immunohistochemistry was u...

Alternative Titles

Full title

Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_815966021

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_815966021

Other Identifiers

ISSN

0167-594X,1573-7373

E-ISSN

1573-7373

DOI

10.1007/s11060-010-0245-2

How to access this item